Is there a role of adjuvant radiotherapy in patients with primary resectable gastric cancer?

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter O. Trifanescu
Citation Annals of Oncology (2016) 27 (2): 1-85. 10.1093/annonc/mdw199
Authors O. Trifanescu1, I. Gruia2, R. Anghel1, R. Toma2, B. Tiberiu3, R. Ionescu2, C. Ionescu2, L. Gales4
  • 1UMF Carol Davila Bucharest, Al Trestioreanu Bucharest Institute of Oncology, Bucharest, Romania, /
  • 2Al Trestioreanu Bucharest Institute of Oncology, Bucharest, Romania, /
  • 3Al Trestioreanu Bucharest of Oncology, Bucharest, Romania, /
  • 4Bucharest Institute of Oncology, Bucharest, Romania, /

Abstract

Gastric cancer is a common neoplastic disease and is the third leading cause of cancer death in the world, with differences among geographic areas. Without adjuvant treatment such as chemotherapy and radiotherapy the rate of local recurrence and metastasis is high. The aim of this study is to evaluate the results of adjuvant radiotherapy at patients with resectable gastric cancer.